Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 469 to 472 of 472 entries
Sorted by: Best Match Show Resources per page
Atopic dermatitis and atopic march: which link?.

Acta bio-medica : Atenei Parmensis

Maiello N, Giannetti A, Ricci G, Cinicola B, Carello R, Indolfi C, Caffarelli C, Marseglia A, Calvani M, Miraglia Del Giudice M, Galli E.
PMID: 34842584
Acta Biomed. 2021 Nov 29;92:e2021525. doi: 10.23750/abm.v92iS7.12430.

There is a long standing debate on the atopic march in childhood. The natural progression of allergic manifestations may be considered as comorbidities, which occur more frequently in a specific evolutive age. On the other hand, the natural history...

Cite
Maiello N, Giannetti A, Ricci G, et al. Atopic dermatitis and atopic march: which link?. Acta Biomed. 2021;92:e2021525doi: 10.23750/abm.v92iS7.12430.
Maiello, N., Giannetti, A., Ricci, G., Cinicola, B., Carello, R., Indolfi, C., Caffarelli, C., Marseglia, A., Calvani, M., Miraglia Del Giudice, M., & Galli, E. (2021). Atopic dermatitis and atopic march: which link?. Acta bio-medica : Atenei Parmensis, 92e2021525. https://doi.org/10.23750/abm.v92iS7.12430
Maiello, Nunzia, et al. "Atopic dermatitis and atopic march: which link?." Acta bio-medica : Atenei Parmensis vol. 92 (2021): e2021525. doi: https://doi.org/10.23750/abm.v92iS7.12430
Maiello N, Giannetti A, Ricci G, Cinicola B, Carello R, Indolfi C, Caffarelli C, Marseglia A, Calvani M, Miraglia Del Giudice M, Galli E. Atopic dermatitis and atopic march: which link?. Acta Biomed. 2021 Nov 29;92:e2021525. doi: 10.23750/abm.v92iS7.12430. PMID: 34842584.
Copy Download .nbib Format: NLM
Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating high-performance liquid chromatography method for sepiwhite.

Journal of separation science

Davoodi J, Majidi S, Jahani M, Tayarani-Najaran Z, Golmohammadzadeh S, Kamali H.
PMID: 34669262
J Sep Sci. 2021 Dec;44(24):4299-4312. doi: 10.1002/jssc.202100388. Epub 2021 Nov 02.

Sepiwhite is a novel anti-pigmenting agent that is derived from fatty acid and phenylalanine and used for hyperpigmentation induced by light exposure or inflammation. In this study, a simple and validated high-performance liquid chromatography method for the quantitation of...

Cite
Davoodi J, Majidi S, Jahani M, et al. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating high-performance liquid chromatography method for sepiwhite. J Sep Sci. 2021;44(24):4299-4312doi: 10.1002/jssc.202100388.
Davoodi, J., Majidi, S., Jahani, M., Tayarani-Najaran, Z., Golmohammadzadeh, S., & Kamali, H. (2021). Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating high-performance liquid chromatography method for sepiwhite. Journal of separation science, 44(24), 4299-4312. https://doi.org/10.1002/jssc.202100388
Davoodi, Javid, et al. "Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating high-performance liquid chromatography method for sepiwhite." Journal of separation science vol. 44,24 (2021): 4299-4312. doi: https://doi.org/10.1002/jssc.202100388
Davoodi J, Majidi S, Jahani M, Tayarani-Najaran Z, Golmohammadzadeh S, Kamali H. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating high-performance liquid chromatography method for sepiwhite. J Sep Sci. 2021 Dec;44(24):4299-4312. doi: 10.1002/jssc.202100388. Epub 2021 Nov 02. PMID: 34669262.
Copy Download .nbib Format: NLM
A narrative review of therapies for scalp dermatomyositis.

Dermatologic therapy

Kolla AM, Liu L, Shaw K, Shapiro J, Femia A, Lo Sicco K.
PMID: 34549494
Dermatol Ther. 2021 Nov;34(6):e15138. doi: 10.1111/dth.15138. Epub 2021 Sep 30.

Cutaneous involvement of the scalp is a common manifestation of dermatomyositis (DM), occurring in up to 82% of adults with DM. Scalp DM predominantly affects women and is characterized by dermatitis, alopecia, pruritus, and/or burning. While cutaneous DM negatively...

Cite
Kolla AM, Liu L, Shaw K, et al. A narrative review of therapies for scalp dermatomyositis. Dermatol Ther. 2021;34(6):e15138doi: 10.1111/dth.15138.
Kolla, A. M., Liu, L., Shaw, K., Shapiro, J., Femia, A., & Lo Sicco, K. (2021). A narrative review of therapies for scalp dermatomyositis. Dermatologic therapy, 34(6), e15138. https://doi.org/10.1111/dth.15138
Kolla, Avani M, et al. "A narrative review of therapies for scalp dermatomyositis." Dermatologic therapy vol. 34,6 (2021): e15138. doi: https://doi.org/10.1111/dth.15138
Kolla AM, Liu L, Shaw K, Shapiro J, Femia A, Lo Sicco K. A narrative review of therapies for scalp dermatomyositis. Dermatol Ther. 2021 Nov;34(6):e15138. doi: 10.1111/dth.15138. Epub 2021 Sep 30. PMID: 34549494.
Copy Download .nbib Format: NLM
Protective multi-epitope candidate vaccine for urinary tract infection.

Biotechnology reports (Amsterdam, Netherlands)

Oloomi M, Javadi M, Asadi Karam MR, Khezerloo JK, Haghri Z, Bouzari S.
PMID: 33304840
Biotechnol Rep (Amst). 2020 Nov 26;28:e00564. doi: 10.1016/j.btre.2020.e00564. eCollection 2020 Dec.

Urinary tract infections (UTIs) are induced by exogenous organisms including extraintestinal pathogenic such as

Cite
Oloomi M, Javadi M, Asadi Karam MR, et al. Protective multi-epitope candidate vaccine for urinary tract infection. Biotechnol Rep (Amst). 2020;28:e00564doi: 10.1016/j.btre.2020.e00564.
Oloomi, M., Javadi, M., Asadi Karam, M. R., Khezerloo, J. K., Haghri, Z., & Bouzari, S. (2020). Protective multi-epitope candidate vaccine for urinary tract infection. Biotechnology reports (Amsterdam, Netherlands), 28e00564. https://doi.org/10.1016/j.btre.2020.e00564
Oloomi, Mana, et al. "Protective multi-epitope candidate vaccine for urinary tract infection." Biotechnology reports (Amsterdam, Netherlands) vol. 28 (2020): e00564. doi: https://doi.org/10.1016/j.btre.2020.e00564
Oloomi M, Javadi M, Asadi Karam MR, Khezerloo JK, Haghri Z, Bouzari S. Protective multi-epitope candidate vaccine for urinary tract infection. Biotechnol Rep (Amst). 2020 Nov 26;28:e00564. doi: 10.1016/j.btre.2020.e00564. eCollection 2020 Dec. PMID: 33304840; PMCID: PMC7711219.
Copy Download .nbib Format: NLM
Showing 469 to 472 of 472 entries